**Chapter 8**

[34] Hanasono MM, Friel MT, Klem C,

factors in oral squamous cell carcinoma: A retrospective study of 334 cases. Journal of Oral and Maxillofacial

[43] Leon X, Martinez V, Lopez M, et al. Second, third, and fourth head and neck tumors. A progressive decrease in survival. Head & Neck. 2012;**34**(12):

Surgery. 2008;**66**:1570

1716-1719

microsurgery in patients with advanced oral cavity cancers. Head & Neck. 2009;

[35] Hanasono MM, Friel MT, Klem C,

microsurgery in patients with advanced oral cavity cancers. Head & Neck. 2009;

[36] Cooper JS, Pajak TF, Forastiere AA,

[37] Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. The New England Journal of Medicine.

[38] Available from: http://seer.cancer. gov/csr/1975\_2007/ [Accessed: 14

[39] Shah JP, Cendon RA, Farr HW, Strong EW. Carcinoma of the oral cavity. Factors affecting treatment failure at the primary site and neck. American Journal of Surgery. 1976;**132**:

[40] Gil Z, Carlson DL, Boyle JO, et al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer. 2009;**115**:5700

[41] Myers JN, Greenberg JS, Mo V, Roberts D. Extracapsular spread. A significant predictor of treatment failure

carcinoma of the tongue. Cancer. 2001;

histopathologic independent prognostic

in patients with squamous cell

[42] Arduino PG, Carrozzo M, Chiecchio A, et al. Clinical and

et al. Impact of reconstructive

et al. Impact of reconstructive

et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. The New England Journal of Medicine. 2004;**350**(19):

2004;**350**(19):1945-1952

**31**:1289-1296

*Oral Diseases*

**31**(10):1289-1296

1937-1944

March 2011]

504

**92**:3030

**104**
